Manufacturer record
Mepro Pharmaceuticals Pvt. Ltd.; (Unit II): regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Mepro Pharmaceuticals Pvt. Ltd.; (Unit II) (Gujarat) were declared Not of Standard Quality between April 2024 and May 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
2 records linked to Mepro Pharmaceuticals Pvt. Ltd.; (Unit II) in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Cyra Tablets, Rabeprazole Sodium Tablets IP | CA21868Mfg 2023-07 · Exp 2025-06 | NOT OF STANDARD QUALITY The tablets does not complies in buffer stage for the dissolution test parameter, hence it is NOT OF STANDARD QUALITY.Dissolution | State Lab Drugs Control Laboratory, TelanganaState lab | May 2024 |
| Rabeprazole Sodium Tablets IP (CYRA) | CA21880Mfg 2023-08 · Exp 2025-07 | does not conform to IP Standards with respect to the test for dissolutionDissolution | State Food & Drugs Lab GoaState lab | Apr 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.